top of page

Spotlight: December 2022–January 2023

Updated: Feb 14

Words by Jade Williams

GOLD looks back at some of the top news stories from the pharmaceutical industry over the last few months, covering new disease awareness initiatives, landmark drug approvals, mergers and acquisitions and more

08 December 2022

EUCOPE launches Rare Disease Moonshot initiative to find treatments for rare conditions

12 December 2022

Amgen acquires Horizon Therapeutics for $27.8bn

13 December 2022

Novartis joins Roche and Cancer Research UK’s DETERMINE rare cancers study

19 December 2022

CHMP recommends AstraZeneca’s Forxiga in the EU for chronic heart failure

04 January 2023

Moderna makes first acquisition in purchase of OriCiro Genomics for $85m

07 January 2023

FDA approves Eisai and Biogen’s Alzheimer’s disease treatment lecanemab

09 January 2023

Deloitte study finds ROI in pharma R&D declined sharply in 2022

10 January 2023

BioNTech acquires InstaDeep to strengthen AI-powered drug development

12 January 2023

HBA names Christi Shaw, CEO, Kite Pharma, as 2023 Woman of the Year

13 January 2023

Moderna extends its roots in the UK by becoming latest member of the ABPI

17 January 2023

Ipsos survey names pharma second most trusted sector in Great Britain

26 January 2023

NICE recommends Gilead’s CAR T-cell therapy for NHS treatment of lymphoma

This news round up appears in GOLD 26 – read the full issue here.

Read next

Subscribe to GOLD


Sign up to receive a weekly roundup of our latest articles, interviews and more 

bottom of page